XML 18 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2015
Operating expenses      
General and administrative $ 5,008,275 $ 8,334,740 $ 4,836,978
Research and development 10,672,086 7,254,303 2,271,736
Total operating expenses (15,680,361) (15,589,043) (7,108,714)
Other income (expenses)      
Grant income 140,942 141,195
Research and development incentive income 2,022,902 571,093
Interest income (expense) , net 88,098 11,322 (71,825)
Gain on settlement of accounts payable 75,204 151,402
Gain on settlement of debt 61,205
Financing related charges and adjustments (5,812) (4,998,145)
Foreign exchange gain (loss) (47,583) (48,445) 70,554
Total other income (expense), net 2,279,563 881,960 (4,999,416)
Net loss before provision for income taxes (13,400,798) (14,707,083) (12,108,130)
Income tax expense 59,607 29,615
Net loss and comprehensive loss $ (13,460,405) $ (14,736,698) $ (12,108,130)
Loss per share      
Basic and diluted (in dollars per share) $ (0.33) $ (0.42) $ (0.65)
Weighted average number of shares outstanding      
Basic and diluted (in shares) 40,841,033 35,153,426 18,584,820